Literature DB >> 32368386

The roles and mechanisms of YTH domain-containing proteins in cancer development and progression.

Shuiping Liu1,2,3,4, Guohua Li1,3,4, Qiujie Li1,3,4, Qin Zhang1,3,4, Lvjia Zhuo1,3,4, Xiaying Chen1,3,4, Bingtao Zhai1,3,4, Xinbing Sui1,3,4, Ke Chen5, Tian Xie1,3,4.   

Abstract

Evolutionarily conserved YT521-B homology (YTH) domain-containing proteins, including YTHDF1-3 and YTHDC1-2, are known to confer m6A-dependent RNA-binding activity. The YTH domain-containing proteins participate in numerous RNA processes, such as mRNA splicing, nuclear export, translation and decay in post-transcriptional regulation. Most recently, it has been found that YTH domain-containing proteins play important roles in post-transcriptional modification process hence modulate the expression of genes involved in cancer and other processes including cell cycle progression, cell proliferation, migration and invasion, inflammatory, immunity and autophagy. In this review, we summarize the roles and molecular mechanisms of YTH domain-containing proteins in cancer development and progression. In addition, we discuss the prospect of using YTH domain-containing proteins as a new diagnostic biomarkers and therapeutic targets for cancers. AJCR
Copyright © 2020.

Entities:  

Keywords:  YTH domain-containing proteins; biomarker; m6A modification; tumorigenesis and development

Year:  2020        PMID: 32368386      PMCID: PMC7191095     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  22 in total

Review 1.  Epigenetic regulation in the neurogenic niche of the adult dentate gyrus.

Authors:  Ryan N Sheehy; Luis J Quintanilla; Juan Song
Journal:  Neurosci Lett       Date:  2021-11-11       Impact factor: 3.046

2.  METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.

Authors:  Qiu-Ying Du; Fu-Chun Huo; Wen-Qi Du; Xiao-Lin Sun; Xin Jiang; Lan-Sheng Zhang; Dong-Sheng Pei
Journal:  Oncogene       Date:  2022-08-20       Impact factor: 8.756

3.  Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.

Authors:  Mateja Condic; Damian J Ralser; Niklas Klümper; Jörg Ellinger; Maryam Qureischi; Eva K Egger; Glen Kristiansen; Alexander Mustea; Thore Thiesler
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

4.  N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.

Authors:  Yuanlei Chen; Zeyi Lu; Chao Qi; Chenhao Yu; Yang Li; Wang Huan; Ruyue Wang; Wenqin Luo; Danyang Shen; Lifeng Ding; Liangliang Ren; Haiyun Xie; Dingwei Xue; Mingchao Wang; Kangxin Ni; Liqun Xia; Jun Qian; Gonghui Li
Journal:  Mol Cancer       Date:  2022-05-10       Impact factor: 41.444

5.  YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.

Authors:  Xiangxiang Liu; Jian Qin; Tianyi Gao; Chenmeng Li; Bangshun He; Bei Pan; Xueni Xu; Xiaoxiang Chen; Kaixuan Zeng; Mu Xu; Chengbin Zhu; Yuqin Pan; Huiling Sun; Li Sun; Tao Xu; Shukui Wang
Journal:  Mol Ther Nucleic Acids       Date:  2020-10-04       Impact factor: 8.886

6.  Genome-wide identification and characterization of YTH domain-containing genes, encoding the m6A readers, and their expression in tomato.

Authors:  Shuangqin Yin; Qiujing Ao; Caiyun Tan; Yingwu Yang
Journal:  Plant Cell Rep       Date:  2021-06-03       Impact factor: 4.570

7.  The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene.

Authors:  Shuiping Liu; Qiujie Li; Guohua Li; Qin Zhang; Lvjia Zhuo; Xuemeng Han; Mingming Zhang; Xiaying Chen; Ting Pan; Lili Yan; Ting Jin; Jianjun Wang; Qun Lv; Xinbing Sui; Tian Xie
Journal:  Cell Death Dis       Date:  2020-11-11       Impact factor: 8.469

Review 8.  N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction.

Authors:  Jinming Li; Lei Liang; Yongzhi Yang; Xinxiang Li; Yanlei Ma
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

9.  YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.

Authors:  Xudong Shen; Kui Zhao; Liming Xu; Guilian Cheng; Jianhong Zhu; Lei Gan; Yongyou Wu; Zhixiang Zhuang
Journal:  Front Genet       Date:  2021-01-11       Impact factor: 4.599

10.  An integrative microenvironment approach for laryngeal carcinoma: the role of immune/methylation/autophagy signatures on disease clinical prognosis and single-cell genotypes.

Authors:  Xueran Kang; Yisheng Chen; Bin Yi; Xiaojun Yan; Chenyan Jiang; Bin Chen; Lixing Lu; Yuxing Sun; Runjie Shi
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.